Results 251 to 260 of about 72,644 (316)

Malignant pleural mesothelioma treated with cytoreductive video-assisted thoracic surgery plus hyperthermic intrathoracic chemotherapy: a case report. [PDF]

J Thorac Dis
Li D, Cao Y, Petrella F, Zou Y.
europepmc   +1 more source

Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping Review. [PDF]

Curr Oncol
Lippi L, de Sire A, Aprile V, Calafiore D, Folli A, Refati F, Balduit A, Mangogna A, Ivanova M, Venetis K, Fusco N, Invernizzi M.   +11 more
europepmc   +1 more source

Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma. [PDF]

Mar Drugs
Luna-Nophal A, Díaz-Castillo F, Izquierdo-Sánchez V, Velázquez-Fernández JB, Orozco-Morales M, Lara-Mejía L, Bernáldez-Sarabia J, Sánchez-Campos N, Arrieta O, Díaz-Chávez J, Castañeda-Sánchez JI, Licea-Navarro AF, Muñiz-Hernández S.   +12 more
europepmc   +1 more source

Effect of intraoperative hyperthermic intrathoracic chemotherapy after pleurectomy decortication for treatment of malignant pleural mesothelioma: a comparative study. [PDF]

Updates Surg
Elsayed HH, Sharkawy HY, Ahmed MA, Abdel-Gayed M, Eldewer M.   +4 more
europepmc   +1 more source

Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment. [PDF]

Sci Rep
Karatkevich D, Losmanova T, Zens P, Deng H, Dubey C, Zhang T, Casty C, Gao Y, Neppl C, Berezowska S, Wang W, Peng RW, Schmid RA, Dorn P, Marti TM.   +14 more
europepmc   +1 more source

Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma. [PDF]

Cancers (Basel)
Yun KM, Bazhenova L.
europepmc   +1 more source

Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma. [PDF]

J Exp Clin Cancer Res
Salaroglio IC, Aviles P, Kopecka J, Merlini A, Napoli F, Righi L, Novello S, Sullivan H, Cuevas C, Scagliotti GV, Riganti C.   +10 more
europepmc   +1 more source

Case report: targeted therapy of malignant pleural mesothelioma with anaplastic lymphoma kinase receptor tyrosine kinase gene fusion mutation by crizotinib. [PDF]

J Int Med Res
Wu Y, Zhao Y, Yu L, Wang R, Feng W, Wu Y, Wang L, Chen H, He Z, Wang Q.   +9 more
europepmc   +1 more source

PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first-line therapy. [PDF]

Noncoding RNA Res
Gurau A, Yamauchi S, Ecoff K, Rodgers KP, Eshleman JR, Jr CCT, Huang P, Choi J, Forde PM, Anagnostou V, Brock M, Mei Y.   +11 more
europepmc   +1 more source